Fact CheckerSign in

NCT07597083Recruiting

Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Efficacy of Biofeedback-Assisted Pelvic Floor Muscle Training on Pelvic Radiation-Induced Sexual Dysfunction and Pelvic Floor Dysfunction in Cervical Cancer Survivors : A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

This randomized controlled trial aims to evaluate the efficacy of biofeedback-assisted pelvic floor muscle training on radiation-induced sexual dysfunction in cervical cancer survivors following pelvic radiotherapy. Participants will be randomly assigned to receive either biofeedback-assisted pelvic floor rehabilitation or supervised conventional pelvic floor muscle training without biofeedback for 8 weeks.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
13 May 2026
Start date
19 May 2026
Primary completion date
15 Mar 2027
Lead sponsor
Beni-Suef University
NCT number
NCT07597083

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 19 May 2026 to the primary completion date, 15 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in pelvic floor muscle training or biofeedback-based rehabilitation within the previous 6 months.

Other illness

  • Evidence of recurrent, persistent, or metastatic cervical cancer.
  • Active pelvic infection, pelvic inflammatory disease, or untreated vaginal infection.
  • Ongoing significant vaginal bleeding of unknown or pathological origin.
  • Untreated or active urinary tract infection at the time of enrollment.
  • Neurological disorders affecting pelvic floor function (e.g., spinal cord injury, multiple sclerosis).
  • Severe psychiatric illness or uncontrolled mental health disorder affecting participation.
  • Cognitive impairment preventing understanding of instructions or adherence to protocol.

Other

  • Presence of severe pelvic organ prolapse (stage III-IV).
  • Current pregnancy or planning pregnancy during the study period.
  • Participation in another interventional clinical or rehabilitation trial within the last 3 months or during the study period.

Who the study is looking for

  • Female participants aged 30-60 years.
  • Histologically confirmed diagnosis of cervical cancer (any stage at diagnosis) and completion of primary treatment.
  • Completion of pelvic radiotherapy (external beam radiotherapy and/or brachytherapy) ≥3 months prior to enrollment.
  • Presence of radiation-induced sexual dysfunction, defined as a Female Sexual Function Index (FSFI) score ≤26.55.
  • Self-reported sexual activity within the previous 6 months.
  • Medically stable with no current oncologic indication for active treatment, confirmed by treating oncologist.
  • Ability to understand study procedures and provide written informed consent.

Age in the registry: 30 years to 60 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Out patient clinic , faculty of Physical Therapy, Beni Sueif university
Coordinator of this site? Confirm its status
Banī SuwayfEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.